Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Lars Fruergaard Jorgensen
Lars Fruergaard Jorgensen
Weight loss drugs like Ozempic have food CEOs so 'scared' they're calling Novo Nordisk for advice
Quartz
Thu, 02/15/24 - 07:20 pm
Novo Nordisk
Lars Fruergaard Jorgensen
Ozempic
Wegovy
weight loss
Novo Nordisk CEO Jørgensen nets a 13% raise for 2023 amid soaring demand for Wegovy, Ozempic
Fierce Pharma
Wed, 02/7/24 - 09:15 pm
Novo Nordisk
executive pay
Lars Fruergaard Jorgensen
Pharma CEOs
JPM24: In booming obesity field, Novo Nordisk is 'just getting going,' CEO says
Fierce Pharma
Wed, 01/10/24 - 06:27 pm
Novo Nordisk
obesity
Wegovy
Lars Fruergaard Jorgensen
JPMHC 2024
Novo CEO expects patients to stay on Wegovy longer than older weight loss drugs
Reuters
Tue, 01/9/24 - 09:59 pm
Novo Nordisk
Pharma CEOs
Wegovy
patients
Lars Fruergaard Jorgensen
JPMHC 2024
Weight-Loss Drug Wegovy Will Launch In More Countries Despite Ongoing Struggles Over Stellar Demand, CEO Says
Forbes
Fri, 08/25/23 - 09:48 am
Novo Nordisk
Wegovy
Lars Fruergaard Jorgensen
weight loss
Novo Nordisk CEO Jørgensen aims to leverage diabetes know-how, deals into the new decade
Fierce Pharma
Wed, 11/20/19 - 10:45 pm
Novo Nordisk
Lars Fruergaard Jorgensen
Pharma CEOs
diabetes
[video]Novo Nordisk CEO Sees Competition in U.S. Driving Down Prices
Bloomberg
Sun, 03/4/18 - 09:58 am
Novo Nordisk
Pharma CEOs
competition
drug pricing
Lars Fruergaard Jorgensen